The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review
S Hasani-Ranjbar, N Nayebi, L Moradi… - Current …, 2010 - ingentaconnect.com
Objective: This review focuses on the efficacy and safety of effective herbal medicines in the
management of hyperlipidemia in human. Methods: PubMed, Scopus, Google Scholar, Web …
management of hyperlipidemia in human. Methods: PubMed, Scopus, Google Scholar, Web …
Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors
TE Toms, DP Symmons… - Current vascular …, 2010 - ingentaconnect.com
Rheumatoid arthritis (RA) associates with excess cardiovascular morbidity and mortality,
resulting in significantly shortened lifespan. Traditional risk factors (eg dyslipidaemia and …
resulting in significantly shortened lifespan. Traditional risk factors (eg dyslipidaemia and …
Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
RY Gordon, T Cooperman, W Obermeyer… - Archives of internal …, 2010 - jamanetwork.com
Background Red yeast rice (RYR) is a widely available dietary supplement used by millions
of patients as an alternative therapy for hyperlipidemia. It contains 14 active compounds …
of patients as an alternative therapy for hyperlipidemia. It contains 14 active compounds …
Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance
SC Halbert, B French, RY Gordon, JT Farrar… - The American journal of …, 2010 - Elsevier
Currently, no consensus has been reached regarding the management of hyperlipidemia in
patients who develop statin-associated myalgia (SAM). Many statin-intolerant patients use …
patients who develop statin-associated myalgia (SAM). Many statin-intolerant patients use …
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo …
F Affuso, A Ruvolo, F Micillo, L Sacca… - Nutrition, Metabolism and …, 2010 - Elsevier
BACKGROUND AND AIMS: Some nutraceuticals are prescribed as lipid-lowering
substances. However, doubts remain about their efficacy. We evaluated the effects of a …
substances. However, doubts remain about their efficacy. We evaluated the effects of a …
Effect of Xuezhikang Capsule (血脂康胶囊) on serum tumor necrosis factor-α and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia
X Fan, Y Deng, L Ye, Y Li, J Chen, W Lu, J Li - Chinese journal of …, 2010 - Springer
Objective To evaluate the effect of Xuezhikang Capsule (血脂康胶囊) on the serum levels of
inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in …
inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in …
Lipid-lowering efficacy of red yeast rice in a population intolerant to statins
CV Venero, JV Venero, DC Wortham… - The American journal of …, 2010 - Elsevier
Chinese red yeast rice is a dietary supplement containing monacolins, unsaturated fatty
acids, and phytosterols capable of lowering low-density lipoprotein (LDL) cholesterol. Few …
acids, and phytosterols capable of lowering low-density lipoprotein (LDL) cholesterol. Few …
HypoCol (red yeast rice) lowers plasma cholesterol–a randomized placebo controlled study
MP Bogsrud, L Ose, G Langslet, I Ottestad… - Scandinavian …, 2010 - Taylor & Francis
Objective. The primary endpoint in our study was to investigate the effect of a red yeast rice
(RYR) product on plasma lipids. Design. A randomized, double-blind, placebo controlled …
(RYR) product on plasma lipids. Design. A randomized, double-blind, placebo controlled …
Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review
PS Nijjar, FM Burke, A Bloesch, DJ Rader - Journal of clinical lipidology, 2010 - Elsevier
Coronary heart disease (CHD) remains a major source of morbidity and mortality. As the
epidemic of obesity, diabetes, and hypertension continues to grow among young adults, the …
epidemic of obesity, diabetes, and hypertension continues to grow among young adults, the …
Approach to the patient who is intolerant of statin therapy
RH Eckel - The Journal of Clinical Endocrinology & Metabolism, 2010 - academic.oup.com
Myopathy occurs in approximately 10% of statin-treated patients and is most commonly
manifested by myalgias with or without plasma creatine kinase (CK) elevations …
manifested by myalgias with or without plasma creatine kinase (CK) elevations …